All About Multiple Sclerosis

More MS news articles for December 2003

Summary Of Research Progress - 2003

December 12, 2003
The National Multiple Sclerosis Society

The year of 2003 saw rapid research progress in the fields of science and medicine that impact our understanding of the unpredictable neurological disease of multiple sclerosis. Thanks to its generous contributors, the National MS Society was able to invest nearly $33 million this year into MS research projects in the U.S. and abroad. In 2003, the Society supported over 300 MS research projects including the launch of 121 new projects. To support special targeted research initiatives, so far the Society has committed more than $21.4 million toward the MS Lesion Project, the Sonya Slifka Longitudinal MS Study, and individual projects exploring genetic aspects of MS and gender differences.

Significant advances have been made in both clinical and laboratory studies in MS. In addition, nearly 160 clinical trials are underway around the world, and still other experimental drugs are in the pipeline. Key highlights of the year include:

In 2003, great strides were made in the development and testing of novel therapies for MS. Further clinical trials to confirm exciting, early findings may bring about more treatment options for people with this disease.

Copyright © 2003, The National Multiple Sclerosis Society